AORT

Artivion Inc

Stock NYSE – Stock Market Prices, News & Analysis

Artivion Inc specializes in medical devices and the preservation of biological tissues used in various surgical procedures.

$ 37.74
1.56 %

Artivion Inc

$ 37.74
1.56 %
AORT

Artivion Inc specializes in medical devices and the preservation of biological tissues used in various surgical procedures.

Price history of Artivion Inc
Price history of Artivion Inc

Performance & Momentum

6 Months 13.04 %
1 Year 58.24 %
3 Years 168.23 %
5 Years 29.34 %

Strategic Analysis

Artivion Inc • 2026

Artivion Inc operates in a specialized niche in cardiovascular and aortic surgery devices and solutions, a highly technical medical segment with high barriers to entry. Its positioning is based on products that are critical for complex procedures, giving it a differentiated value proposition in medical devices.

Strengths
  • Highly focused expertise in cardiovascular and aortic surgery
  • Niche market with specialized clinical needs and high technical barriers
  • Strong long-term stock market performance, suggesting value creation appreciated by the market
Weaknesses
  • Sensitive to the pace of clinical adoption and hospital spending cycles
  • Valuation profile that may be more demanding after a strong recent run
Momentum

Momentum appears favorable and of good quality, with a clearly positive underlying trend despite a recent short-term consolidation. The trend remains constructive over intermediate and long-term horizons, reflecting sustained market interest in its niche positioning and execution. For retail investors, the stock retains an aggressive profile within healthcare, but with volatility to watch after a pronounced rise.

Similar stocks to Artivion Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone